Liverpool Medicaid spending for COVID-19 services hits $251,669 in 2024

In 2024, Liverpool recorded at least $251,669 in Medicaid payments for services billed under HCPCS codes directly related to COVID-19, data from the U.S. Department of Health and Human Services Medicaid Provider Spending database shows.

Medicaid is a state-operated public health insurance program funded jointly by both federal and state governments. It serves low-income individuals and families, seniors, children, and those with disabilities, making it a major segment of the U.S. health system.

Because Medicaid is publicly funded, shifts in billing volumes at the local level demonstrate how taxpayer-financed health care resources are allocated across communities.

For this report, COVID-19–related services included HCPCS codes labeled or denoted as “COVID-19” or “coronavirus” in the billing description or in reference records. Thus, the totals reflect only those services explicitly billed as COVID-19–related and do not cover pandemic care categorized under broader or unrelated medical billing codes.

In comparison, Brooklyn documented the highest Medicaid spending for COVID-19 services within New York in 2024, totaling $3,718,101 in related claims.

Three Liverpool providers billed Medicaid for COVID-19–specific services in 2024. Immunoassay was among the highest-charged codes, comprising $226,225.

On average, each Liverpool provider received $83,890 from Medicaid for COVID-19–related services, well above the $29,403 state average.

Multiple years during the pandemic saw COVID-19–designated services significantly power Medicaid spending increases in Liverpool.

Aggregate Medicaid payments across all other claim types rose by $6,828,642 from 2020 to 2024, marking a 33.2% gain.

The two years leading up to the pandemic saw average Medicaid payments in Liverpool at $11,306,257 each year.

Figures from the Centers for Medicare & Medicaid Services indicate that combined Medicaid spending at the federal and state levels reached approximately $871.7 billion during fiscal year 2023. This accounted for around 18% of total national health spending and jumped from about $613.5 billion in 2019, before the COVID-19 crisis.

This represents roughly 40% growth over a few years, predominantly driven by higher enrollment and use during the pandemic and post-pandemic period.

Recent federal budget actions under the Trump administration featured major proposals to cut federal Medicaid funding and overhaul the program. For instance, the “One Big Beautiful Bill Act,” enacted in 2025, is expected to reduce federal Medicaid spending by more than $1 trillion in the next decade and brings policies like work requirements and greater cost-sharing, which may decrease coverage and state funding for some enrollees. Such revisions are anticipated to shift added costs to individual states and limit further federal Medicaid outlays, even as the program continues to assist tens of millions across the country.

Note: Totals reflect only HCPCS codes specifically designated for COVID-19 services; this does not include all pandemic-related health spending.

Data supporting this article comes from the U.S. Department of Health and Human Services Medicaid Provider Spending database, available here.